 Vancouver, British Columbia and Minneapolis, Minnesota--Newsfile Corp. - June 18, 2021 - Neovasc Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company today announced the publication of an article entitled, Safety and Efficacy of Coronary Sinus Narrowing in Chronic Refractory Angina: Insights from the RESOURCE Study in the International Journal of Cardiology.The article, authored by Francesco Ponticelli, M.D., Maria Cecilia Hospital, Cotignola, Italy, describes long-term outcomes of patients suffering from refractory angina treated with the Neovasc ReducerTM Reducer... 